We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Lithia Motors
LAD
$8.35B
| $12.1M | 0.02% |
+33,752
| New | +$11.9M |
|
327
Check Point Software Technologies
CHKP
$13.4B
| $12M | 0.02% |
64,344
+2,610
| +4% | +$492K |
|
328
Employers Holdings
EIG
$877M
| $11.9M | 0.02% |
233,020
-15,849
| -6% | -$805K |
|
329
STAG Industrial
STAG
$7.08B
| $11.8M | 0.01% |
349,712
-10,778
| -3% | -$394K |
|
330
Limbach Holdings
LMB
$559M
| $11.8M | 0.01% |
138,199
| – | – |
|
331
Johnson & Johnson
JNJ
$625B
| $11.8M | 0.01% |
81,593
-6,018
| -7% | -$933K |
|
|
TXNM
332
TXNM Energy Inc
TXNM
$5.91B
| $11.7M | 0.01% |
238,800
| – | – |
|
333
KB Home
KBH
$3.45B
| $11.6M | 0.01% |
176,440
-10,987
| -6% | -$855K |
|
334
Core & Main
CNM
$8.67B
| $11.4M | 0.01% |
223,105
-61,678
| -22% | -$2.91M |
|
335
V2X
VVX
$2.62B
| $11.2M | 0.01% |
235,047
| – | – |
|
336
TechnipFMC
FTI
$29B
| $11.2M | 0.01% |
386,427
+367,522
| +1,944% | +$10.5M |
|
337
Abbott
ABT
$188B
| $11.1M | 0.01% |
97,971
-1,145
| -1% | -$132K |
|
|
MAGN
338
Magnera Corp
MAGN
$459M
| $11M | 0.01% |
+603,687
| New | +$12.4M |
|
339
ANI Pharmaceuticals
ANIP
$1.75B
| $10.7M | 0.01% |
194,185
+19,568
| +11% | +$1.12M |
|
|
MRC
340
DELISTED
MRC Global
MRC
| $10.7M | 0.01% |
837,609
-21,026
| -2% | -$275K |
|
341
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $10.6M | 0.01% |
277,038
| – | – |
|
342
Mercury Systems
MRCY
$6.48B
| $10.6M | 0.01% |
251,908
| – | – |
|
343
John Wiley & Sons Class A
WLY
$2.63B
| $10.5M | 0.01% |
240,654
+34,373
| +17% | +$1.69M |
|
344
Cedar Fair
FUN
$1.63B
| $10.5M | 0.01% |
217,266
+83,473
| +62% | +$3.66M |
|
345
Emerson Electric
EMR
$89B
| $10.5M | 0.01% |
84,415
-9,646
| -10% | -$1.17M |
|
346
iShares MBS ETF
MBB
$38.9B
| $10.4M | 0.01% |
113,979
+109,910
| +2,701% | +$10.2M |
|
347
Ingersoll Rand
IR
$33.6B
| $10.2M | 0.01% |
113,120
-23,386
| -17% | -$2.33M |
|
348
Pinterest
PINS
$13.6B
| $10.2M | 0.01% |
+351,806
| New | +$11.1M |
|
349
Astrana Health
ASTH
$1.84B
| $10.1M | 0.01% |
319,666
-202,443
| -39% | -$9.62M |
|
350
McGrath RentCorp
MGRC
$2.93B
| $10M | 0.01% |
89,858
| – | – |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.